Voyager Therapeutics, Inc.
MX ˙ BMV ˙ US92915B1061
SecurityMX:VYGR / Voyager Therapeutics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership3,428,571 shares
Latest Disclosed Value $ 13,234,284
Millennium Management Llc ownership in VYGR / Voyager Therapeutics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 3,428,571 shares of Voyager Therapeutics, Inc. (MX:VYGR) valued at $13,234,284 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,880,760 shares of Voyager Therapeutics, Inc.. This represents a change in shares of 82.30% during the quarter.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (VYGR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:VYGR / Voyager Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 3,428,571 1,547,811 82.30 13,234 79.06 0.0055
2026-02-17 2025-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,880,760 -411,943 -17.97 7,391 -30.96 0.0031
2025-11-14 2025-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 2,292,703 1,389,542 153.85 10,707 281.27 0.0046
2025-08-14 2025-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 903,161 804,679 817.08 2,809 745.78 0.0014
2025-05-15 2025-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 98,482 2,304 2.40 333 -39.08 0.0002
2025-02-14 2024-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 96,178 -60,935 -38.78 545 -40.70 0.0003
2024-11-14 2024-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 157,113 157,113 919 0.0004
2024-08-14 2024-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 0 -100,725 -100.00 0 -100.00
2024-05-15 2024-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 100,725 100,725 938 0.0004
2024-02-14 2023-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 0 -11,085 -100.00 0 -100.00
2023-11-14 2023-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 11,085 -4,135 -27.17 86 -51.15 0.0000
2023-08-14 2023-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 15,220 -1,147,333 -98.69 174 -98.06 0.0001
2023-05-15 2023-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,162,553 883,899 317.20 8,963 427.24 0.0051
2023-02-14 2022-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 278,654 -44,221 -13.70 1,700 -11.04 0.0009
2022-11-14 2022-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 322,875 -505,921 -61.04 1,911 -60.98 0.0011
2022-08-15 2022-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 828,796 646,814 355.43 4,898 253.14 0.0030
2022-05-16 2022-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 181,982 -241,076 -56.98 1,387 21.03 0.0007
2022-02-14 2021-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 423,058 149,698 54.76 1,146 59.39 0.0006
2021-11-15 2021-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 273,360 -244,502 -47.21 719 -66.39 0.0004
2021-08-16 2021-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 517,862 517,862 2,139 0.0013
2020-08-14 2020-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 0 -222,298 -100.00 0 -100.00
2020-05-14 2020-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 222,298 -270,365 -54.88 2,034 -70.41 0.0046
2020-02-14 2019-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 492,663 492,663 121.62 6,873 237.91 0.0086
2019-11-14 2019-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 0 -488,281 -100.00 0 -100.00
2019-08-15 2019-06-30 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 488,281 343,213 236.59 13,291 378.61 0.0200
2019-05-14 2019-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 145,068 -264,202 -64.55 2,777 -27.81 0.0042
2019-02-15 2018-12-31 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 409,270 -58,346 -12.48 3,847 -56.52 0.0060
2019-02-14 2018-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 409,270 3,847
2018-11-14 2018-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 467,616 -152,302 -24.57 8,847 -26.96 0.0108
2018-08-14 2018-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 619,918 1,897 0.31 12,113 4.31 0.0158
2018-05-15 2018-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 618,021 342,148 124.02 11,613 153.61 0.0155
2018-02-14 2017-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 275,873 275,873 4,579 0.0063
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VOYAGER THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F VOYAGER THERAPEUTICS COM Call 44,800 -10.93 176 -24.79 n/a n/a n/a
2025-11-14 2025-09-30 13F VOYAGER THERAPEUTICS COM Call 50,300 235 n/a n/a n/a
2022-08-15 2022-06-30 13F VOYAGER THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F VOYAGER THERAPEUTICS COM Call 30,000 229 n/a n/a n/a
2019-11-14 2019-09-30 13F HILL ROM HLDGS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F HILL ROM HLDGS COM Call 10,200 1,067 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.